Loading...
Assessment of Carfilzomib Treatment Response in Lung Transplant Recipients With Antibody-mediated Rejection
Data supporting the use of carfilzomib (CFZ) for treatment of antibody-mediated rejection (AMR) in lung transplantation in combination with plasmapheresis and intravenous immunoglobulin suggest positive outcomes through donor-specific antibody (DSA) depletion or conversion to noncomplement-activatin...
Na minha lista:
| Udgivet i: | Transplant Direct |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Lippincott Williams & Wilkins
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7969244/ https://ncbi.nlm.nih.gov/pubmed/33748409 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001131 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|